Reaction profile

The FDA adverse-event record for joint pain

566 FDA reports name joint pain, a high-volume reaction in the CVM extract (VeDDRA 588). Plate stamps and neighbourhood peers follow.

#594 of 2,481
by report volume (all reactions)
566
reports citing this reaction
12.4%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Joint pain has 566 reports now versus 538 in that prior snapshot: 28 more (5.2%).

Report change
+28
Death-coded reports
+9
Death-coded share
+1.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Joint pain changes

FDA AER · VeDDRA plate

Code 588 VOL-MID

VOL-MID · DEATH-ELEV · UPPER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-MID 566 reports
  • DEATH-ELEV 12.4%
  • UPPER-Q #594/2481
  • PHOTO-FINISH Mass NOS
  • SPECIES-DOG Dog · 473
  • DRUG-LEAD Carprofen · 85
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Mass NOS (±0 reports)

Upper-third report volume drives the scale stamps on this plate; death-coded share and co-report peers follow. Not a clinical diagnosis.

High-volume neighbourhood around Joint pain

Upper-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Head down · near571Joint pain · this reaction566Mass NOS · near566Oral bleeding · near566Regenerative anaemia · near566Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Joint pain

What the FDA AER plate says about Joint pain

Signature read: 566 reports place Joint pain in the upper third of FDA AER volume (#594 of 2,481). Report volume is upper-third scale: 566 named reports in the openFDA extract. 70 of 566 reports were death-coded (12.4% of named reports, not a population mortality rate). Nearest volume peer: Mass NOS (±0 reports). Lead species Dog (473). Lead co-reported drug Carprofen (85).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Carprofen appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 473
Cat 39
Human 26
Horse 26
Pig 1
Cattle 1

Breeds Most Affected

Retriever - Labrador 64
Retriever - Golden 33
Crossbred Canine/dog 31
Unknown 28
Shepherd Dog - German 25
Domestic Shorthair 19
Boxer (German Boxer) 14
Dog (unknown) 13
Shih Tzu 11
Beagle 10

Associated Drugs

Carprofen 85
Bedinvetmab 70
Milbemycin Oxime + Spinosad 64
Trilostane 39
Gabapentin 39
Oclacitinib Maleate 28
Afoxolaner 28
Enrofloxacin 27
Fluralaner Chew Tablets 26
Prednisone 24
Maropitant Citrate 20
Moxidectin 19
Spinosad 18
Milbemycin Oxime + Praziquantel 18
Ivermectin + Pyrantel As Pamoate Salt 15
Fluralaner 13.64% 12-Week Chew 15
Hyaluronate Sodium 14
Meloxicam 14
Milbemycin Oxime 14
Cefovecin 14

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Joint pain, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar report volume

Nearest other reactions by FDA report count (566 here).

Similar death-coded share

Nearest other reactions by death-coded share (12.4% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Joint pain (#594 of 2,481 by report volume); death-coded 12.4%. PlainBreed reaction plate · report volume stamp 566 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →